Cerevance
PrivateLast Round
Series C
May 12, 2026
Total Funding Raised
$209.5M
Company Overview
Cerevance is a biotechnology company focused on developing innovative therapeutics to create new treatments for central nervous system diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cerevance Comps
Public and private peers based on sector, stage, and business model.
Cerevance Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 12, 2026 | ||||
| Series B Extension | Apr 25, 2024 | ||||
| Series B Extension | Feb 13, 2023 | ||||
| Series B Extension | Jul 21, 2020 | ||||
| Series B | Apr 14, 2020 | ||||
VC Round | Feb 21, 2018 |
Cerevance Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agent Capital | Series B Extension |
| Dolby Family Ventures | Series B Extension |
| SV Health Investors | Series C |
| GV | Series C, Series B Extension, Series B |
| Lightstone Ventures | Series C, Series B Extension, Series B, Series A |
| Bioluminescence Ventures | Series B Extension |
| Foresite Capital | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
$20M round with participation from GV and UPMC Enterprises.
- Apr 18, 2026
Presenting at the American Academy of Neurology 2026 Annual Meeting.
Cerevance Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cerevance's valuation, stock price, and market status.
